ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ocuphire Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market
June 09, 2021Ocuphire Pharma, announced today the closing of its previously announced registered direct offering of 3,076,923 shares of the Company's common stock (the "Shares") and warrants to purchase 1,538,461 shares of the Company's common stock (the "Warrants" -
Ocuphire Announces Completion of the First of Two Trials for Nyxol® Eye Drops
September 06, 2019Ocuphire Pharma has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019. The objectives of the randomized...
Pharma Sources Insight January 2025
